A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
Academic Article
Publication Date:
2023
Short description:
A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia / Kittai, A. S.; Skarbnik, A.; Miranda, M.; Yong, A. S. M.; Roos, J.; Hettle, R.; Palazuelos-Munoz, S.; Shetty, V.; Ghia, P.. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 98:12(2023), pp. 387-390. [10.1002/ajh.27110]
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
List of contributors:
Kittai, A. S.; Skarbnik, A.; Miranda, M.; Yong, A. S. M.; Roos, J.; Hettle, R.; Palazuelos-Munoz, S.; Shetty, V.; Ghia, P.
Published in: